These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

675 related items for PubMed ID: 22611017

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Playing only one instrument may be not enough: limitations and future of the antiangiogenic treatment of cancer.
    Quesada AR, Medina MA, Alba E.
    Bioessays; 2007 Nov; 29(11):1159-68. PubMed ID: 17935210
    [Abstract] [Full Text] [Related]

  • 5. [Antiangionic drugs in soft tissue sarcoma].
    Salas S, Huynh T, Deville JL, Duffaud F.
    Bull Cancer; 2010 Jun; 97(6):701-5. PubMed ID: 20483703
    [Abstract] [Full Text] [Related]

  • 6. VEGF inhibition and metastasis: possible implications for antiangiogenic therapy.
    English BC, Price DK, Figg WD.
    Cancer Biol Ther; 2009 Jul; 8(13):1214-25. PubMed ID: 19483467
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of anti-angiogenesis agents in treating NSCLC: focus on bevacizumab and VEGFR tyrosine kinase inhibitors.
    Cabebe E, Wakelee H.
    Curr Treat Options Oncol; 2007 Feb; 8(1):15-27. PubMed ID: 17634832
    [Abstract] [Full Text] [Related]

  • 9. Targeting angiogenesis in esophagogastric adenocarcinoma.
    Okines AF, Reynolds AR, Cunningham D.
    Oncologist; 2011 Feb; 16(6):844-58. PubMed ID: 21632459
    [Abstract] [Full Text] [Related]

  • 10. [Novelties in the treatment for advanced renal-cell cancer].
    Maráz A.
    Orv Hetil; 2011 Apr 24; 152(17):655-62. PubMed ID: 21464023
    [Abstract] [Full Text] [Related]

  • 11. Targeted treatment for metastatic renal cell carcinoma and immune regulation.
    Laschos KA, Papazisis KT, Kontovinis LF, Kalaitzis C, Gianakopoulos S, Kortsaris AH, Touloupidis S.
    J BUON; 2010 Apr 24; 15(2):235-40. PubMed ID: 20658715
    [Abstract] [Full Text] [Related]

  • 12. Anti-angiogenic therapy: concept to clinic.
    Young RJ, Reed MW.
    Microcirculation; 2012 Feb 24; 19(2):115-25. PubMed ID: 22078005
    [Abstract] [Full Text] [Related]

  • 13. [Angiogenesis targeting in renal carcinomas].
    Pouessel D, Culine S.
    Bull Cancer; 2007 Feb 24; 94(7 Suppl):F223-6. PubMed ID: 17965000
    [Abstract] [Full Text] [Related]

  • 14. Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice.
    Agostino NM, Chinchilli VM, Lynch CJ, Koszyk-Szewczyk A, Gingrich R, Sivik J, Drabick JJ.
    J Oncol Pharm Pract; 2011 Sep 24; 17(3):197-202. PubMed ID: 20685771
    [Abstract] [Full Text] [Related]

  • 15. Antiangiogenic therapy promoted metastasis of hepatocellular carcinoma by suppressing host-derived interleukin-12b in mouse models.
    Zhu XD, Sun HC, Xu HX, Kong LQ, Chai ZT, Lu L, Zhang JB, Gao DM, Wang WQ, Zhang W, Zhuang PY, Wu WZ, Wang L, Tang ZY.
    Angiogenesis; 2013 Oct 24; 16(4):809-20. PubMed ID: 23716000
    [Abstract] [Full Text] [Related]

  • 16. Antitumor effect of vascular endothelial growth factor inhibitor sunitinib in preclinical models of hepatocellular carcinoma.
    Bagi CM, Gebhard DF, Andresen CJ.
    Eur J Gastroenterol Hepatol; 2012 May 24; 24(5):563-74. PubMed ID: 22314934
    [Abstract] [Full Text] [Related]

  • 17. [Angiogenesis and renal cell carcinoma].
    Billemont B, Méric JB, Izzedine H, Taillade L, Sultan-Amar V, Rixe O.
    Bull Cancer; 2007 Jul 24; 94 Spec No():S232-40. PubMed ID: 17846009
    [Abstract] [Full Text] [Related]

  • 18. Angiogenesis regulated by VEGF and its receptors and its clinical application.
    Shibuya M.
    Rinsho Ketsueki; 2009 May 24; 50(5):404-12. PubMed ID: 19483401
    [No Abstract] [Full Text] [Related]

  • 19. Sorafenib and sunitinib in the treatment of advanced non-small cell lung cancer.
    Gridelli C, Maione P, Del Gaizo F, Colantuoni G, Guerriero C, Ferrara C, Nicolella D, Comunale D, De Vita A, Rossi A.
    Oncologist; 2007 Feb 24; 12(2):191-200. PubMed ID: 17296815
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.